OS-040-YI Claudin-1 is a mediator and therapeutic target of biliary fibrosis by modulating liver progenitor cell fate and signaling

Fabio Del Zompo, Émilie Crouchet, Tessa Ostyn, Frank Jühling, Julien Moehlin, Natascha Roehlen, Tallulah Andrews, Diana Nakib, Cátia T. Perciani, Sai Chung, Gary L. Bader, Ian D. McGilvray, Sonya A. MacParland, Roberto Iacone, Geoffrey Teixeira, Mathias Heikenwälder, Olivier Govaere, Tania Roskams, Catherine Schuster, Laurent Mailly, Thomas F. BaumertJournal of Hepatology 2024 · DOI

BibTeX
@article{zompo2024os,
  author = {Fabio Del Zompo and Émilie Crouchet and Tessa Ostyn and Frank Jühling and Julien Moehlin and Natascha Roehlen and Tallulah Andrews and Diana Nakib and Cátia T. Perciani and Sai Chung and Gary L. Bader and Ian D. McGilvray and Sonya A. MacParland and Roberto Iacone and Geoffrey Teixeira and Mathias Heikenwälder and Olivier Govaere and Tania Roskams and Catherine Schuster and Laurent Mailly and Thomas F. Baumert},
  title = {{OS-040-YI Claudin-1 is a mediator and therapeutic target of biliary fibrosis by modulating liver progenitor cell fate and signaling}},
  journal = {Journal of Hepatology},
  year = {2024},
  doi = {10.1016/s0168-8278(24)00481-1},
}

Loading related content...

Figure